Amphastar P (AMPH)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 144,296 | 156,098 | 126,353 | 92,642 | 73,685 |
Short-term investments | US$ in thousands | 112,510 | 19,664 | 10,320 | 12,977 | 11,675 |
Receivables | US$ in thousands | 114,943 | 88,804 | 78,804 | 66,005 | 45,376 |
Total current liabilities | US$ in thousands | 225,407 | 94,862 | 103,810 | 112,201 | 90,009 |
Quick ratio | 1.65 | 2.79 | 2.08 | 1.53 | 1.45 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($144,296K
+ $112,510K
+ $114,943K)
÷ $225,407K
= 1.65
The quick ratio of Amphastar Pharmaceuticals Inc has shown fluctuations over the past five years. As of December 31, 2023, the quick ratio stands at 1.69, indicating a slightly lower level of liquidity compared to the previous year. In 2022, the quick ratio was significantly higher at 2.87, reflecting a strong ability to meet short-term obligations with liquid assets.
In 2021, the quick ratio was 2.15, a favorable level of liquidity that suggests the company had more than enough liquid assets to cover its short-term liabilities. The quick ratio dipped to 1.59 in 2020, indicating a slight decrease in liquidity compared to the previous year.
Overall, the trend in the quick ratio of Amphastar Pharmaceuticals Inc shows fluctuations but generally remains above 1, which implies the company has sufficient liquid assets to cover its short-term liabilities. Investors and analysts may want to monitor the quick ratio closely to assess the company's ability to meet its short-term obligations efficiently.
Peer comparison
Dec 31, 2023